These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1794174)

  • 1. Langerhans-cell histiocytosis--excellent response to etoposide.
    Mayou SC; Chu AC; Munro DD; Plowman N
    Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
    Broadbent V; Pritchard J; Yeomans E
    Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
    Yu LC; Shenoy S; Ward K; Warrier RP
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adult Langerhans cell histiocytosis with etoposide.
    Tsele E; Thomas DM; Chu AC
    J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis.
    Helmbold P; Hegemann B; Holzhausen HJ; Klapperstück T; Marsch WC
    Arch Dermatol; 1998 Oct; 134(10):1275-8. PubMed ID: 9801684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral, skin and bone multisystem Langerhans cell histiocytosis and its response to etoposide--a case report.
    Sheehan MP; Chu AC
    Clin Exp Dermatol; 1991 Nov; 16(6):463-6. PubMed ID: 1806325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone.
    Körholz D; Janssen G; Göbel U
    Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Langerhans cell histiocytosis in children with etoposide.
    Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
    Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
    Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
    Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
    Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
    Pedrol E; Estruch R; Marrades RM; Ingelmo M
    Rev Clin Esp; 1991 Apr; 188(6):319. PubMed ID: 1780535
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
    Narula G; Pradhan ND; Arora B; Banavali SD
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Langerhans cell histiocytosis in the elderly].
    Gerlach B; Stein A; Fischer R; Wozel G; Dittert DD; Richter G
    Hautarzt; 1998 Jan; 49(1):23-30. PubMed ID: 9522189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulvar ulcer as a presentation of systemic Langerhans cell histiocytosis.
    Madnani NA; Khan KJ
    Indian J Dermatol Venereol Leprol; 2011; 77(2):177-9. PubMed ID: 21393948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
    Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
    Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cell histiocytosis of the optic chiasm.
    Gangwani V; Walker M; El-Defrawy H; Nicoll JA; Reck A; Pathmanathan T
    Clin Exp Ophthalmol; 2007; 35(1):66-8. PubMed ID: 17300575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine.
    Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M
    Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.